The global telepsychiatry market was valued at USD 14.20 billion in 2024 and is projected to reach USD 16.28 billion in 2025, with an anticipated growth to USD 51.79 billion by 2032. This represents a robust compound annual growth rate (CAGR) of 18.0% over the forecast period. North America led the market in 2024, accounting for a dominant share of 46.9%.

The telepsychiatry market is experiencing substantial growth, driven by the increasing prevalence of mental health disorders, growing acceptance of virtual healthcare services, and advancements in digital communication technologies. Telepsychiatry enables the remote delivery of psychiatric assessment, counseling, and medication management, making mental health services more accessible, especially in rural and underserved areas.

Continue reading for more details:

**https://www.fortunebusinessinsights.com/telepsychiatry-market-112083**

Market Segmentation

• By service type, the telepsychiatry market includes assessments, therapy sessions, medication management, and crisis intervention.
• The telepsychiatry market is segmented by delivery mode into video conferencing, phone consultations, and chat/text platforms.
• According to end-user, the telepsychiatry market caters to hospitals, outpatient clinics, mental health centers, and private practices.
• The telepsychiatry market also segments by age group, serving children, adolescents, adults, and geriatric patients.
• Based on condition, the telepsychiatry market addresses anxiety, depression, PTSD, ADHD, bipolar disorder, and substance abuse.

List Of Key Telepsychiatry Companies Profiled:

• Array Behavioral Care (U.S.)
• Teladoc Health, Inc. (U.S.)
• American Well (U.S.)
• Telemynd (U.S.)
• Advanced Telemed Services (U.S.)
• American Telepsychiatrists (U.S.)
• Iris Telehealth Inc. (U.S.)
• MDLIVE (U.S.)